High Ficolin-3 Level at the Time of Transplantation Is an Independent Risk Factor for Graft Loss in Kidney Transplant Recipients

Background Recent studies have shown that activation of the complement system may be associated with long-term graft function. The aim of this retrospective study was to assess the impact of the pattern recognition molecules of the lectin pathway on long-term graft survival after kidney transplantation. Methods Patients transplanted in 2000 to 2001 were included. Mannose-binding lectin, Ficolin-1, and Ficolin-3 were measured in serum at the time of transplantation. Data on death-censored graft loss were obtained from the Norwegian Renal Registry. Competing risks regression was used to investigate the association between time to graft loss and the explanatory variables. The variables were: high Ficolin-3 (upper quartile, ≥33.3 &mgr;g/mL) versus low Ficolin-3 (<33.3 &mgr;g/mL), acute rejection (time-dependent), age, basiliximab induction, sex, donor age, human leukocyte antigen mismatches, human leukocyte antigen antibodies, cold ischemia time, living donor, and preemptive transplantation. Results A total of 382 patients with a median follow-up of 9.8 years were included. Sixty-six patients (17%) had death-censored graft loss, and 116 (30%) patients died. In a final competing risks model, high Ficolin-3 (subhazard ratio [SHR] = 1.95, P = 0.009), acute rejection (one vs. none) (SHR = 1.93, P = 0.033), acute rejection (two vs. none) (SHR = 5.45, P < 0.001), and age (SHR = 0.98, P = 0.006) were associated with death-censored graft loss. Basiliximab induction was associated with improved graft survival (SHR = 0.50, P = 0.016). No associations between mannose-binding lectin or Ficolin-1 and graft loss were found. Conclusion High Ficolin-3 level at the time of transplantation was an independent significant risk factor for shorter graft survival, even when adjusted for other covariates.

[1]  J. Thurman,et al.  The role of the complement system in acute kidney injury. , 2013, Seminars in nephrology.

[2]  S. Thiel,et al.  Humoral Pattern Recognition and the Complement System , 2013, Scandinavian journal of immunology.

[3]  T. Fujita,et al.  Structural and Functional Overview of the Lectin Complement Pathway: Its Molecular Basis and Physiological Implication , 2013, Archivum Immunologiae et Therapiae Experimentalis.

[4]  S. Sørensen,et al.  Pre-transplant levels of ficolin-3 are associated with kidney graft survival. , 2013, Clinical immunology.

[5]  S. Sørensen,et al.  Low mannose-binding lectin serum levels are associated with reduced kidney graft survival. , 2013, Kidney international.

[6]  M. Seelen,et al.  Mannan binding lectin: a two-faced regulator of renal allograft injury? , 2013, Kidney international.

[7]  M. Stegall,et al.  The role of complement in antibody-mediated rejection in kidney transplantation , 2012, Nature Reviews Nephrology.

[8]  A. Butte,et al.  Progressive histological damage in renal allografts is associated with expression of innate and adaptive immunity genes. , 2011, Kidney international.

[9]  A. Rahmel,et al.  Systemic Complement Activation in Deceased Donors Is Associated With Acute Rejection After Renal Transplantation in the Recipient , 2011, Transplantation.

[10]  H. van Goor,et al.  Local renal complement C3 induction by donor brain death is associated with reduced renal allograft function after transplantation. , 2011, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[11]  K. Lamb,et al.  Long‐Term Renal Allograft Survival in the United States: A Critical Reappraisal , 2011, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[12]  Junchao Cai,et al.  Induction Immunosuppression Improves Long-Term Graft and Patient Outcome in Organ Transplantation: An Analysis of United Network for Organ Sharing Registry Data , 2010, Transplantation.

[13]  A. Hartmann,et al.  Experience From an Active Preemptive Kidney Transplantation Program—809 Cases Revisited , 2009, Transplantation.

[14]  A. Butte,et al.  Expression of complement components differs between kidney allografts from living and deceased donors. , 2009, Journal of the American Society of Nephrology : JASN.

[15]  J. Fernández-Real,et al.  Low Serum Mannose-Binding Lectin as a Risk Factor for New Onset Diabetes Mellitus After Renal Transplantation , 2009, Transplantation.

[16]  H. Nielsen,et al.  Characteristics and Biological Variations of M-Ficolin, a Pattern Recognition Molecule, in Plasma , 2009, Journal of Innate Immunity.

[17]  S. Thiel,et al.  Impact of the complement lectin pathway on cytomegalovirus disease early after kidney transplantation. , 2008, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[18]  Robert B Sim,et al.  Comparative study of the human ficolins reveals unique features of Ficolin-3 (Hakata antigen). , 2008, Molecular immunology.

[19]  A. Hartmann,et al.  Kidney transplantation in the elderly--the Norwegian experience. , 2007, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[20]  S. Thiel,et al.  Quantification of mannan-binding lectin. , 2006, Journal of immunological methods.

[21]  S. Thiel,et al.  Early posttransplant serum osteoprotegerin levels predict long-term (8-year) patient survival and cardiovascular death in renal transplant patients. , 2006, Journal of the American Society of Nephrology : JASN.

[22]  J. D. de Fijter,et al.  Association Between Mannose‐Binding Lectin Levels and Graft Survival in Kidney Transplantation , 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[23]  M. Mack,et al.  Steroid withdrawal or steroid avoidance in renal transplant recipients: focus on tacrolimus-based immunosuppressive regimens. , 2005, Transplantation proceedings.

[24]  S. Thiel,et al.  Effect of Capsulation of Opportunistic Pathogenic Bacteria on Binding of the Pattern Recognition Molecules Mannan-Binding Lectin, L-Ficolin, and H-Ficolin , 2005, Infection and Immunity.

[25]  Robert Gray,et al.  A Proportional Hazards Model for the Subdistribution of a Competing Risk , 1999 .

[26]  K. Okochi,et al.  Cloning and Characterization of the Hakata Antigen, a Member of the Ficolin/Opsonin p35 Lectin Family* , 1998, The Journal of Biological Chemistry.

[27]  F. Moreso,et al.  Innate immunity in renal transplantation: the role of mannose-binding lectin. , 2014, Transplantation reviews.

[28]  H. Meier‐Kriesche,et al.  Kidney allograft survival: the long and short of it. , 2011, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[29]  S. Thiel,et al.  Assays for the functional activity of the mannan-binding lectin pathway of complement activation. , 2002, Immunobiology.